Pharmaceutical Distribution DX Startup 9lione Raises 120 Million Yen in Series A Funding, Bringing Total to 440 Million Yen
📄 Table of Contents
Overview of Funding
9lione Inc., the developer of the pharmaceutical distribution improvement DX platform "9lione," has raised a total of 120 million yen in its Series A round. With Yokohama Capital acting as the lead investor, alongside Incubate Fund, MSIVC (Mitsui Sumitomo Insurance Capital), DG Ventures, Globe Advisors, NanoBank, as well as angel investors and debt financing, the company's cumulative funding now reaches 440 million yen.
About 9lione Inc.
9lione Inc. is a startup aiming to optimize pharmaceutical distribution. Having obtained a pharmaceutical wholesale license, the company operates not merely as a matching service, but as a wholesale business that holds and manages inventory in-house. By ensuring traceability compliant with GDP (Good Distribution Practice) guidelines, 9lione is dedicated to streamlining inventory management for medical institutions and resolving pharmaceutical shortages.
Purpose of Funding and Future Outlook
The newly raised funds will primarily be allocated to the following three areas:
1. Expansion of the logistics network: Sequentially expanding logistics and sales bases to serve medical institutions nationwide.
2. Product development: Advancing AI-driven inventory visualization and transaction automation to reduce the operational burden on medical frontlines.
3. Strengthening the organizational structure: Accelerating recruitment in areas such as pharmaceutical affairs, product management, and engineering.
Looking ahead, 9lione aims to establish its framework for delivering surplus pharmaceuticals to medical institutions in need as a vital social infrastructure. The company also plans to expand its stable supply functions at fair prices through AI-based demand forecasting.
List of Investors
- Yokohama Capital (Lead Investor)
- Incubate Fund
- MSIVC (Mitsui Sumitomo Insurance Capital)
- DG Ventures
- Globe Advisors
- NanoBank
- Angel Investors
- Debt Financing